These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32170986)

  • 1. Absence of significant association between UGT2B4 genetic variants and the susceptibility to anti-tuberculosis drug-induced liver injury in a Western Chinese population.
    Chen H; Jiao L; Zhou J; Bai H; Lyu M; Wu T; Wu L; Song J; Liu T; Yan H; Ying B
    J Clin Pharm Ther; 2021 Feb; 46(1):66-73. PubMed ID: 32170986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han.
    Chen G; Wu SQ; Feng M; Wang Y; Wu JC; Ji GY; Zhang MM; Liu QQ; He JQ
    Int J Immunopathol Pharmacol; 2017 Dec; 30(4):434-438. PubMed ID: 28934901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of LEPR polymorphisms with predisposition and inflammatory response in anti-tuberculosis drug-induced liver injury: A pilot prospective investigation in Western Chinese Han population.
    Zhao Z; Peng W; Zhou J; Zhou Y; Liu T; Bai H; Wu Q; Song J; Wu L; Song X; Ying B
    Infect Genet Evol; 2019 Nov; 75():103970. PubMed ID: 31325611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
    Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
    J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
    Xiang Y; Ma L; Wu W; Liu W; Li Y; Zhu X; Wang Q; Ma J; Cao M; Wang Q; Yao X; Yang L; Wubuli A; Merle C; Milligan P; Mao Y; Gu J; Xin X
    PLoS One; 2014; 9(1):e85905. PubMed ID: 24465778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
    Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
    J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.
    Tang SW; Lv XZ; Chen R; Wu SS; Yang ZR; Chen DF; Zhan SY
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):326-32. PubMed ID: 23469989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population.
    Tao B; Yang M; Chen H; Pan H; Liu W; Yi H; Tang S
    J Clin Pharm Ther; 2020 Aug; 45(4):638-645. PubMed ID: 32259340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
    Shang P; Xia Y; Liu F; Wang X; Yuan Y; Hu D; Tu D; Chen Y; Deng P; Cheng S; Zhou L; Ma Y; Zhu L; Gao W; Wang H; Chen D; Yang L; He P; Wu S; Tang S; Lv X; Shu Z; Zhang Y; Yang Z; Chen Y; Li N; Sun F; Li X; He Y; Garner P; Zhan S
    PLoS One; 2011; 6(7):e21836. PubMed ID: 21750735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury.
    Wu S; Wang Y; Zhang M; Wang M; He JQ
    Therapie; 2019 Jun; 74(3):399-406. PubMed ID: 30093157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment].
    Chen R; Wang J; Tang SW; Lyu XZ; Zhang Y; Wu SS; Xia YY; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):925-9. PubMed ID: 27453098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Sun F; Chen Y; Xiang Y; Zhan S
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):994-1002. PubMed ID: 18713495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.
    Chen S; Pan H; Chen Y; Lu L; He X; Chen H; Chen R; Zhan S; Tang S
    Sci Rep; 2019 Oct; 9(1):14311. PubMed ID: 31586142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
    Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population.
    Zhang C; Jiao L; Bai H; Zhao Z; Hu X; Wang M; Wu T; Peng W; Liu T; Song J; Zhou J; Li M; Lyv M; Zhang J; Chen H; Chen J; Ying B
    Infect Genet Evol; 2020 Apr; 79():104147. PubMed ID: 31857256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a Case-Control Study.
    Chen R; Zhang Y; Tang S; Lv X; Wu S; Sun F; Xia Y; Zhan SY
    J Clin Pharm Ther; 2015 Feb; 40(1):110-5. PubMed ID: 25250564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ABCC Gene Polymorphism With Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity in Western Han Patients With Tuberculosis.
    Bai H; Wu T; Jiao L; Wu Q; Zhao Z; Song J; Liu T; Lv Y; Lu X; Ying B
    J Clin Pharmacol; 2020 Mar; 60(3):361-368. PubMed ID: 31648372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Polymorphisms in Antioxidant Enzymes Modulate the Susceptibility of Idiosyncratic Antituberculous Drug-Induced Liver Injury and Treatment Outcomes in Patients with Tuberculosis.
    Sun Q; Sha W; Liu HP; Wang P; Liu ZB; Sun WW; Xiao HP
    Pharmacotherapy; 2020 Jan; 40(1):4-16. PubMed ID: 31742742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are genetic variations in glutathione S-transferases involved in anti-tuberculosis drug-induced liver injury? A meta-analysis.
    Zhang M; Wu SQ; He JQ
    J Clin Pharm Ther; 2019 Dec; 44(6):844-857. PubMed ID: 31378997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing Trajectories of Alanine Aminotransferase and Risk of Antituberculosis Drug-Induced Liver Injury in Chinese Patients: A Cohort Study.
    Chen X; Pan H; Hao Z; Yi H; Tang S
    J Clin Pharmacol; 2024 Jul; 64(7):840-848. PubMed ID: 38436510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.